The drug "Platifillina hydrotartrate" is a myotropic antispasmodic with pronounced vasodilating, antispasmodic and sedative properties. The basis of the action of this tool is the suppression of cholinergic systems responsible for the transmission of excitation from parasympathetic nerves directly to the executive organs, as well as the suppression of
vasomotor centers. In addition, the drug "Platifillina hydrotartrate" effectively interferes with internal secretion, lowers the tone of the gall bladder and smooth muscles of the gastrointestinal tract, has a moderate antispasmodic effect, reduces the frequency and amplitude of the peristaltic contractions of the stomach, and helps to smooth the smooth muscles of the urinary tract and uterus. Separately, it is worth noting that the use of this myotropic agent allows you to eliminate the pain syndrome in a short time. It should be emphasized that when using the antispasmodic drug "Platifillina hydrotartrate", you must always remember that it is poisonous and dispensed from pharmacies strictly according to the prescription of the attending physician.
If we talk about the features of the dosage form of release, then this vasodilating agent is produced in the form of tablets and in the form of a 0.2% solution for injection. The active ingredient in this case is the extract of leaves of the broadleaf cross.
A myotropic preparation "Platifillin hydrotartrate" is prescribed, as a rule, for the treatment of patients suffering from a duodenal ulcer or stomach, renal, intestinal or hepatic colic. The list of medical indications also includes inflammatory diseases of the gallbladder and biliary tract. For the treatment of angina pectoris, the purpose of this vasodilating agent is similarly shown, while, naturally, a prescription is required to purchase it. "Platifillina hydrotartrate" is recommended for use in spasms of cerebral vessels, and in the early stages of hypertension. The use of this tool is also indicated for the treatment of bronchial asthma. For diagnostic purposes, this drug is actively used in eye practice.
The use of the medicine "Platifillina hydrotartrate" is strictly not recommended for people with severe diseases of the kidneys and liver, as well as for those who suffer from severe disorders in the work of the cardiovascular system. In addition, this drug is contraindicated in prostate adenoma and glaucoma.
As for the features of the use of this vasodilating drug, here everything is very individual. So, for example, to stop acute pain with a stomach ulcer or colic, first use the drug "Platifillina hydrotartrate" intramuscularly. Subsequently, it is taken orally two to three times a day, 0.5 to 1 tablet. In ocular practice, this myotropic agent is usually used exclusively in the form of a 2% solution. In any case, in each specific situation, the treatment regimen is developed only by the attending physician on the basis of the obtained test results.